- Home
- SUPN vs SAH Comparison
SUPN vs SAH Comparison
Compare SUPN & SAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- SAH
- Stock Information
- Founded
- SUPN 2005
- SAH 1997
- Country
- SUPN United States
- SAH United States
- Employees
- SUPN N/A
- SAH N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- SAH Other Specialty Stores
- Sector
- SUPN Health Care
- SAH Consumer Discretionary
- Exchange
- SUPN Nasdaq
- SAH Nasdaq
- Market Cap
- SUPN 1.9B
- SAH 2.0B
- IPO Year
- SUPN 2012
- SAH 1997
- Fundamental
- Price
- SUPN $35.57
- SAH $63.94
- Analyst Decision
- SUPN Hold
- SAH Buy
- Analyst Count
- SUPN 1
- SAH 5
- Target Price
- SUPN $36.00
- SAH $67.40
- AVG Volume (30 Days)
- SUPN 422.4K
- SAH 208.6K
- Earning Date
- SUPN 11-04-2024
- SAH 10-24-2024
- Dividend Yield
- SUPN N/A
- SAH 2.19%
- EPS Growth
- SUPN 130.79
- SAH N/A
- EPS
- SUPN 1.07
- SAH 5.63
- Revenue
- SUPN $651,972,000.00
- SAH $13,913,300,000.00
- Revenue This Year
- SUPN $7.82
- SAH N/A
- Revenue Next Year
- SUPN N/A
- SAH $3.06
- P/E Ratio
- SUPN $33.25
- SAH $11.35
- Revenue Growth
- SUPN 6.79
- SAH N/A
- 52 Week Low
- SUPN $25.53
- SAH $47.82
- 52 Week High
- SUPN $39.37
- SAH $67.15
- Technical
- Relative Strength Index (RSI)
- SUPN 53.46
- SAH 61.15
- Support Level
- SUPN $35.87
- SAH $64.19
- Resistance Level
- SUPN $39.37
- SAH $67.15
- Average True Range (ATR)
- SUPN 1.69
- SAH 2.12
- MACD
- SUPN 0.03
- SAH 0.52
- Stochastic Oscillator
- SUPN 36.03
- SAH 69.43
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The Company's diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About SAH Sonic Automotive Inc.
Sonic Automotive is one of the largest auto dealership groups in the United States. The company has 108 franchised stores in 18 states, primarily in metropolitan areas in California, Texas, and the Southeast, plus 25 EchoPark used-vehicle stores, 16 collision centers, and 13 powersports locations. The franchise stores derive revenue from new and used vehicles plus parts and collision repair, finance, insurance, and wholesale auctions. Luxury and import dealerships make up about 86% of franchise new-vehicle revenue, while Honda, BMW, Mercedes, and Toyota constitute about 58% of new-vehicle revenue. BMW is the largest brand at about 25%. 2023's revenue was $14.4 billion, with EchoPark's portion totaling $2.4 billion. Sonic bought RFJ Auto in December 2021, which added $3.2 billion in sales.